The Allen Institute is launching a $200 million initiative, the Brain Health Accelerator, to develop gene therapies for neurodegenerative diseases including Alzheimer's, Parkinson's, Huntington's, and ALS. It marks the first time the Seattle research organization, founded by Paul Allen in 2003, has
⚡
Key Insights
10 editorial insights.
AiFeed24 Team·⏱ 1 min read·Startups
Deep Analysis
Multi-Source Intelligence
Tags:#startups
Found this useful? Share it!
Related Stories

🚀Startups
Docusign moving downtown Seattle offices, leaving its namesake tower
about 2 hours ago

🚀Startups
5 Interesting Startup Deals You May Have Missed: On-Demand Custom Manufacturing, Underwater Geothermal Energy, And Adventure Group Travel
about 4 hours ago

🚀Startups
Investors Eye Defense Legal AI As The Next Billion-Dollar Opportunity
about 4 hours ago

🚀Startups
Snowflake champions interoperability as Apache Iceberg gains traction in enterprises
about 12 hours ago
